192 related articles for article (PubMed ID: 15113857)
1. In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis.
Bayard-Mc Neeley M; Bansal A; Chowdhury I; Girao G; Small CB; Seiter K; Nelson J; Liveris D; Schwartz I; Mc Neeley DF; Wormser GP; Aguero-Rosenfeld ME
J Clin Pathol; 2004 May; 57(5):499-503. PubMed ID: 15113857
[TBL] [Abstract][Full Text] [Related]
2. Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis.
Klein MB; Hayes SF; Goodman JL
Infect Immun; 1998 Jul; 66(7):3410-5. PubMed ID: 9632613
[TBL] [Abstract][Full Text] [Related]
3. A case of equine granulocytic ehrlichiosis provides molecular evidence for the presence of pathogenic anaplasma phagocytophilum (HGE agent) in Germany.
Von Loewenich FD; Stumpf G; Baumgarten BU; Röllinghoff M; Dumler JS; Bogdan C
Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):303-5. PubMed ID: 12740667
[TBL] [Abstract][Full Text] [Related]
4. Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis.
Klein MB; Miller JS; Nelson CM; Goodman JL
J Infect Dis; 1997 Nov; 176(5):1405-9. PubMed ID: 9359749
[TBL] [Abstract][Full Text] [Related]
5. The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions.
Borjesson DL; Barthold SW
Comp Med; 2002 Oct; 52(5):403-13. PubMed ID: 12405632
[TBL] [Abstract][Full Text] [Related]
6. Comparative strain analysis of Anaplasma phagocytophilum infection and clinical outcomes in a canine model of granulocytic anaplasmosis.
Scorpio DG; Dumler JS; Barat NC; Cook JA; Barat CE; Stillman BA; DeBisceglie KC; Beall MJ; Chandrashekar R
Vector Borne Zoonotic Dis; 2011 Mar; 11(3):223-9. PubMed ID: 20846015
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of human granulocytic ehrlichiosis in children using rifampin.
Krause PJ; Corrow CL; Bakken JS
Pediatrics; 2003 Sep; 112(3 Pt 1):e252-3. PubMed ID: 12949322
[TBL] [Abstract][Full Text] [Related]
8. Human granulocytic ehrlichiosis in Europe.
Strle F
Int J Med Microbiol; 2004 Apr; 293 Suppl 37():27-35. PubMed ID: 15146982
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of human promyelocytic cells in response to infection with Anaplasma phagocytophilum.
de la Fuente J; Ayoubi P; Blouin EF; Almazán C; Naranjo V; Kocan KM
Cell Microbiol; 2005 Apr; 7(4):549-59. PubMed ID: 15760455
[TBL] [Abstract][Full Text] [Related]
10. Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman.
Lee FS; Chu FK; Tackley M; Wu AD; Atri A; Wessels MR
Clin Infect Dis; 2000 Nov; 31(5):1288-91. PubMed ID: 11073767
[TBL] [Abstract][Full Text] [Related]
11. The risk of exposure to Anaplasma phagocytophilum infection in Mid-Eastern Poland.
Tomasiewicz K; Modrzewska R; Buczek A; Stańczak J; Maciukajć J
Ann Agric Environ Med; 2004; 11(2):261-4. PubMed ID: 15627334
[TBL] [Abstract][Full Text] [Related]
12. Laboratory Maintenance of Anaplasma phagocytophilum.
Carlyon JA
Curr Protoc Microbiol; 2005 Jul; Chapter 3():Unit 3A.2. PubMed ID: 18770564
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous infection with Borrelia burgdorferi and human granulocytic ehrlichiosis.
Moss WJ; Dumler JS
Pediatr Infect Dis J; 2003 Jan; 22(1):91-2. PubMed ID: 12553302
[TBL] [Abstract][Full Text] [Related]
14. Incidence and prevalence of infection with Anaplasma phagocytophilum. Prospective study in healthy individuals exposed to ticks.
Grzeszczuk A; Puzanowska B; Miegoć H; Prokopowicz D
Ann Agric Environ Med; 2004; 11(1):155-7. PubMed ID: 15236514
[TBL] [Abstract][Full Text] [Related]
15. A lifelong study of a pack Rhodesian ridgeback dogs reveals subclinical and clinical tick-borne Anaplasma phagocytophilum infections with possible reinfection or persistence.
Hovius E; de Bruin A; Schouls L; Hovius J; Dekker N; Sprong H
Parasit Vectors; 2018 Apr; 11(1):238. PubMed ID: 29650038
[TBL] [Abstract][Full Text] [Related]
16. Sialyl-Lewis x-independent infection of human myeloid cells by Anaplasma phagocytophilum strains HZ and HGE1.
Sarkar M; Reneer DV; Carlyon JA
Infect Immun; 2007 Dec; 75(12):5720-5. PubMed ID: 17893131
[TBL] [Abstract][Full Text] [Related]
17. Anaplasma phagocytophilum PSGL-1-independent infection does not require Syk and leads to less efficient AnkA delivery.
Reneer DV; Troese MJ; Huang B; Kearns SA; Carlyon JA
Cell Microbiol; 2008 Sep; 10(9):1827-38. PubMed ID: 18485118
[TBL] [Abstract][Full Text] [Related]
18. Wild animals as reservoirs of Anaplasma phagocytophilum for humans.
Dzięgiel B; Adaszek Ł; Winiarczyk S
Przegl Epidemiol; 2016; 70(3):428-435. PubMed ID: 27883378
[TBL] [Abstract][Full Text] [Related]
19. Infection with Anaplasma phagocytophilum in a seronegative patient in Sicily, Italy: case report.
de la Fuente J; Torina A; Naranjo V; Caracappa S; Di Marco V; Alongi A; Russo M; Maggio AR; Kocan KM
Ann Clin Microbiol Antimicrob; 2005 Oct; 4():15. PubMed ID: 16202127
[TBL] [Abstract][Full Text] [Related]
20. Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection.
Lin M; den Dulk-Ras A; Hooykaas PJ; Rikihisa Y
Cell Microbiol; 2007 Nov; 9(11):2644-57. PubMed ID: 17587335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
